| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1466 |
| Trial ID | NCT02028455 |
| Disease | Acute Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia |
| Year | 2014 |
| Country | United States |
| Company sponsor | Seattle Children's Hospital |
| Other ID(s) | PLAT-02 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||